Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
0.5500
0.00 (0.00%)
At close: Mar 20, 2026
TSXV:EBM Revenue
In the fiscal year ending October 31, 2025, Eastwood Bio-Medical Canada had annual revenue of 782.08K CAD with 11.40% growth. Eastwood Bio-Medical Canada had revenue of 365.12K in the quarter ending October 31, 2025, with 105.57% growth.
Revenue
782.08K
Revenue Growth
+11.40%
P/S Ratio
48.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 782.08K | 80.00K | 11.40% |
| Oct 31, 2024 | 702.08K | -165.86K | -19.11% |
| Oct 31, 2023 | 867.94K | -431.83K | -33.22% |
| Oct 31, 2022 | 1.30M | 318.71K | 32.49% |
| Oct 31, 2021 | 981.05K | 262.72K | 36.57% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| George Weston | 64.51B |
| Loblaw Companies | 63.90B |
| Metro | 22.18B |
| Dollarama | 7.04B |
| Swiss Water Decaffeinated Coffee | 258.72M |
| Inter-Rock Minerals | 146.72M |
| The Fresh Factory B.C. | 59.02M |
| InnoCan Pharma | 37.64M |